Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells.
Mutations in the CEBPA gene are present in 7%-10% of human patients with acute myeloid leukemia (AML). However, no genetic models exist that demonstrate their etiological relevance. To mimic the most common mutations affecting CEBPA-that is, those leading to loss of the 42 kDa C/EBPalpha isoform (p4...
Main Authors: | Kirstetter, P, Schuster, M, Bereshchenko, O, Moore, S, Dvinge, H, Kurz, E, Theilgaard-Mönch, K, Månsson, R, Pedersen, T, Pabst, T, Schrock, E, Porse, B, Jacobsen, SE, Bertone, P, Tenen, D, Nerlov, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen.
by: Hasemann, MS, et al.
Published: (2008) -
Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
by: Bereshchenko, O, et al.
Published: (2009) -
The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivo.
by: Porse, B, et al.
Published: (2006) -
C/EBPalpha mutations in acute myeloid leukaemias.
by: Nerlov, C
Published: (2004) -
Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo.
by: Pedersen, T, et al.
Published: (2007)